GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biostem Technologies BSEM · USD

Health Care · US listing · 🇺🇸 United States

Compare

1.12

-0.88%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$301.8m

FY2015FY2024

Net income

$31.9m

FY2015FY2024

Free cash flow

$24.1m

FY2015FY2024

Shareholders' equity

$40.9m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Revenue$301.8m$16.7m$6.9m$4.3m$2.5m$2.6m$1.0m$328,528$607,223$151,536
Research and development$1.9m$341,996$224,775$119,647——————
Operating income$31.2m−$7.8m−$4.7m−$1.6m−$1.8m−$5.7m−$7.8m−$4.8m−$3.7m−$2.4m
Net income$31.9m−$8.5m−$7.1m−$1.4m−$2.4m−$6.3m−$7.6m−$4.8m−$4.0m−$2.4m
Diluted earnings per share3.45-0.92-0.77-0.16-0.26-0.69-0.79-2.34-0.38-0.26

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assets$140.4m$14.6m$3.5m$2.7m$2.7m$3.2m$4.3m$3.0m$2.7m$2.9m
Total liabilities$99.5m$15.5m$7.4m$8.5m$8.3m$7.1m$6.0m$1.6m$2.3m$1.3m
Debt$150,000$265,635$1.0m$1.8m$1.3m$914,349$467,861———
Shareholders' equity$40.9m−$983,675−$3.9m−$5.8m−$5.6m−$3.9m−$1.7m$1.5m$481,076$1.6m
Shares outstanding9m9m9m9m9m9m10m2m10m9m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operations$24.5m−$3.5m−$1.6m−$109,439−$581,566−$845,795−$3.7m−$1.6m−$1.7m−$353,576
Capital spending−$426,569−$210,330−$243,577−$42,848—−$133,588−$198,824−$147,746−$716,705−$1.3m
Free cash flow$24.1m−$3.7m−$1.9m−$152,287−$581,566−$979,383−$3.9m−$1.8m−$2.4m−$1.6m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue311.2%158.2%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin7.4%5.2%2.9%—
Net margin7.3%4.5%1.8%—

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Price to earnings4.0-6.4-2.5-4.2-3.5-1.1-1.2-1.5-7.7-16.0
Price to sales0.43.32.51.43.42.58.721.950.2251.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-73%199%150%233%-35%30%-18%-73%17%-28%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 400-to-1 reverse split · 27 Jan 2015
  • 35-to-1 reverse split · 17 Jan 2013
  • 1000-to-1 reverse split · 31 Oct 2008
  • 100-to-1 reverse split · 30 May 2008
  • 25-to-1 reverse split · 22 Sept 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.